| Not Yet Recruiting | An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone NCT06082817 | San Diego Sexual Medicine | Phase 2 |
| Completed | A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evalua NCT04943068 | Kwang Dong Pharmaceutical co., ltd. | Phase 3 |
| Completed | Improving Female Sexual Wellness NCT04824820 | Cedars-Sinai Medical Center | N/A |
| Completed | A Mindfulness-based Intervention for Older Women With Low Sexual Desire NCT03232801 | University of Pittsburgh | N/A |
| Completed | Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder NCT04179734 | Imperial College Healthcare NHS Trust | Phase 4 |
| Completed | Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters. NCT04336891 | University of Florence | — |
| Completed | Waitlist Controlled Comparison of Cognitive-behavioral vs. Mindfulness-based Online-treatments for Women With NCT03780751 | Ruhr University of Bochum | N/A |
| Completed | BP101 for Adults With Female Sexual Dysfunction NCT03463707 | Ivix LLX | Phase 3 |
| Completed | Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) NCT03287232 | EndoCeutics Inc. | Phase 3 |
| Terminated | Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy NCT02714049 | San Diego Sexual Medicine | Phase 4 |
| Terminated | Effects of Flibanserin on the Pre- and Post-menopausal Female Brain NCT02770768 | University of Chicago | N/A |
| Unknown | Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women NCT02968342 | Bezmialem Vakif University | Phase 4 |
| Completed | A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women NCT02859285 | ProHealth Care, Inc | N/A |
| Completed | Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men NCT02593396 | University of Malaya | Phase 2 |
| Completed | 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire NCT02338960 | Palatin Technologies, Inc | Phase 3 |
| Completed | The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause NCT02419209 | University of Johannesburg | Phase 2 |
| Completed | 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire NCT02333071 | Palatin Technologies, Inc | Phase 3 |
| Completed | Low Sexual Desire and Metabolic Syndrome NCT02430987 | Faculdade de Ciências Médicas da Santa Casa de São Paulo | N/A |
| Completed | Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder NCT02101203 | Emotional Brain NY Inc. | Phase 2 |
| Completed | Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation NCT01743235 | Emotional Brain NY Inc. | Phase 2 |
| Completed | Lybrido for Female Sexual Dysfunction NCT01432665 | Emotional Brain NY Inc. | Phase 2 |
| Completed | Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disor NCT01382719 | Palatin Technologies, Inc | Phase 2 |
| Suspended | A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality NCT00569413 | Hadassah Medical Organization | — |
| Completed | Testosterone Patch's Effects on the Cardiovascular System and Libido NCT01208038 | Imperial College Healthcare NHS Trust | Phase 4 |
| Completed | Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Diso NCT01235754 | BioSante Pharmaceuticals | Phase 3 |
| Terminated | A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray a NCT01096329 | VIVUS LLC | Phase 1 |
| Completed | Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Wo NCT00657501 | BioSante Pharmaceuticals | Phase 3 |
| Completed | Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women NCT00612742 | BioSante Pharmaceuticals | Phase 3 |
| Terminated | Surveillance Study of Women Taking Intrinsa® NCT00551785 | Center for Epidemiology and Health Research, Germany | — |
| Completed | Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women NCT00467259 | Warner Chilcott | Phase 3 |
| Completed | Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausa NCT00613002 | BioSante Pharmaceuticals | Phase 3 |
| Completed | Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen NCT00384046 | Warner Chilcott | Phase 3 |
| Completed | Sexual Dysfunction and Dental Care NCT00281372 | Sheba Medical Center | — |
| Unknown | Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder NCT00916396 | Tel-Aviv Sourasky Medical Center | N/A |
| Completed | Effects of Early Abuse on Adult Intimate Relationships NCT01803802 | University of Texas at Austin | N/A |
| Completed | Testosterone in Female Hypoactive Sexual Desire Disorder NCT00140153 | Beersheva Mental Health Center | Phase 3 |
| Completed | Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido NCT00131495 | Warner Chilcott | Phase 3 |
| Completed | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido NCT00331214 | Warner Chilcott | Phase 3 |
| Completed | Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction NCT00034021 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido NCT00338312 | Warner Chilcott | Phase 3 |
| Completed | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido NCT00331123 | Warner Chilcott | Phase 3 |